Does High Intraoperative Inspired Oxygen Reduce Postoperative Arterial Oxygen Saturation?

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status and phase

Completed
Phase 3
Phase 2

Conditions

Atelectasis

Treatments

Other: FiO2 >0.9 with 3-5 cm water PEEP
Other: FiO2 0.3 without PEEP
Other: FiO2 >0.9 without PEEP
Other: FiO2 (fraction of inspired oxygen) 0.3 plus PEEP (positive end expiratory pressure) 3 -5 cm water

Study type

Interventional

Funder types

Other

Identifiers

NCT00715741
29830

Details and patient eligibility

About

The purpose of this study is to determine whether breathing high levels of oxygen during surgery affects oxygen levels after surgery. The second purpose of this study is to determine whether giving positive end expiratory pressure PEEP and high oxygen together affects patients oxygen levels after surgery.

Full description

This is a randomized, controlled, blinded trial in patients undergoing non-abdominal surgery of the effect of intraoperative increased inspired oxygen used (FiO2>0.9 vs. FiO2 = 0.3) on non-invasive oxygen saturation (pulse oximetry, SpO2) and amount of required supplemental oxygen in the post-anesthesia care unit (PACU); arterial oxygen partial pressure (PaO2) after 45 minutes in the PACU; room air SpO2 24 hours after surgery, and amount of supplemental oxygen required 24 hours after surgery. The purpose of the study is to determine whether absorption atelectasis induced by use of inspired oxygen concentrations in excess of 90% leads to a higher risk of hypoxemia, as evidenced by room air oxygen values and the need for supplemental oxygen. The objective of this study is to determine whether high inspired oxygen (>0.8), which has been demonstrated to reduce the risk of surgical site infection in patients undergoing colon surgery and other major surgical procedures has side effects that limit its use to prevent infection in lower risk operations. There are four groups of intraoperative ventilation management in this study. Fi02 0.3 plus PEEP, Fi02 0.3 without PEEP, Fi02 greater than 0.9 plus PEEP 3 to 5 cm of water, Fi02 greater than 0.9 without PEEP.

Enrollment

100 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients aged 18-70 years undergoing surgery under general endotracheal anesthesia at the University of Utah Hospital Operating Room and the Huntsman Cancer Hospital Operating room who will be admitted to the hospital for at least 24 hours after surgery

Exclusion criteria

  • Major (open) abdominal surgery
  • Major spine surgery
  • Craniotomy surgery
  • Surgeries where electrocautery or laser devices may be used near the airway (eg tracheostomy, oral surgery) because of the risk of fire with high inspired oxygen in these cases
  • Procedures planned for monitored anesthesia care (MAC) or regional without general anesthesia
  • Planned airway management with a laryngeal mask airway rather than an endotracheal tube
  • Procedures planned in the prone position because this increases atelectasis
  • Planned postoperative intubation
  • Planned postoperative care in the intensive care unit
  • Recent (within 3 weeks) chemotherapy because of the increased risk of pulmonary oxygen toxicity
  • History of bleomycin administration because of the increased risk of pulmonary oxygen toxicity
  • Diagnosed Obstructive Sleep Apnea with home continuous pulmonary airway pressure (CPAP) use
  • Home oxygen use
  • Preoperative room air (RA) SpO2 <90%
  • History of spontaneous pneumothorax
  • Emergency surgery
  • Pregnancy. Women of child-bearing age are routinely screened for pregnancy urine human chorionic gonadotropin, (HCG) on the morning of surgery. Patients with a positive result will be excluded from the study (and most likely will have their elective surgery cancelled).
  • Patient refusal

Trial design

100 participants in 4 patient groups

1
Active Comparator group
Description:
Group 1 will receive 30% oxygen plus PEEP + 3 to 5 cm Water duration of anesthesia and surgery
Treatment:
Other: FiO2 (fraction of inspired oxygen) 0.3 plus PEEP (positive end expiratory pressure) 3 -5 cm water
2
Active Comparator group
Description:
Group 2 will receive 30% oxygen without PEEP for the duration of anesthesia and surgery
Treatment:
Other: FiO2 0.3 without PEEP
3
Active Comparator group
Description:
Group 3 will receive > 90% oxygen plus PEEP + 3 to 5 cm of water for the duration of anesthesia and surgery
Treatment:
Other: FiO2 >0.9 with 3-5 cm water PEEP
4
Active Comparator group
Description:
Group 4 will receive > 90% oxygen and no PEEP for the duration of anesthesia and surgery
Treatment:
Other: FiO2 >0.9 without PEEP

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems